Results 1 to 10 of about 2,094 (126)

Misleading hepatitis B serology following Rho (D) immune globulin (human) injection and influenza vaccine [PDF]

open access: yesClinics and Practice, 2018
Having a hepatitis B surface antibody (HBsAb) titre of more than 10 mIU/mL after hepatitis B vaccination is generally considered to confer immunity to hepatitis B.
Xuanxuan Chen
doaj   +6 more sources

Anti-D Alloimmunization in Index Pregnancy after Appropriate Rho(D) Immune Globulin Injection in Two Obese Rh-Negative Patients [PDF]

open access: yesAmerican Journal of Perinatology Reports
Background The rhesus factor D (RhD)-negative patients who give birth to an RhD-positive newborn or who are otherwise exposed to RhD-positive red blood cells are at risk of developing anti-D antibodies. These antibodies may cause hemolytic disease of the fetus and newborn (HDFN).
Stephanie Rodriguez   +3 more
doaj   +4 more sources

Guide to Rho(D) Immune Globulin in Women With Molecularly Defined Asian-type DEL (c.1227G>A). [PDF]

open access: yesAnn Lab Med
Rh hemolytic disease of the fetus and newborn is a potential risk for D-negative mothers who produce anti-D during pregnancy, which can lead to morbidity and mortality in subsequent pregnancies. To prevent this hemolytic disease, Rho(D) immune globulin (RhIG) is generally administered to D-negative mothers without anti-D at 28 weeks of gestation and ...
Jeong IH, Yu S, Kim TY, Oh SY, Cho D.
europepmc   +3 more sources

Recombinant anti-D for prevention of maternal-foetal Rh(D) alloimmunization: a randomized multi-centre clinical trial [PDF]

open access: yesObstetrics & Gynecology Science, 2020
ObjectiveTo compare the efficacy and safety of recombinant anti-D (R-anti-D) with conventional polyclonal anti-D (Poly anti-D) in preventing maternal-fetal rhesus D (RhD) alloimmunization and to investigate the immunogenicity of R-anti-D.MethodsThis was ...
Rahul Vishwanath Mayekar   +13 more
doaj   +1 more source

High dose Intravenous Anti-D Immune Globulin is More Effective and Safe in Indian Paediatric Patients of Immune Thrombocytopenic Purpura [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2016
Introduction: Immune Thrombocytopenia (ITP) is characterised by an autoimmune antibody-mediated destruction of platelets and impaired platelet production.
Trupti Rekha Swain   +2 more
doaj   +1 more source

Isoinmunización Rh en bajas respondedoras: Reporte de caso

open access: yesMedUNAB, 2023
Introducción. La isoinmunización Rh consiste en la producción de anticuerpos maternos en una gestante Rh negativa contra los antígenos de los eritrocitos Rh positivos fetales ocasionados por una hemorragia fetomaterna.
Lady Gabriela Martínez-Carvajal   +2 more
doaj   +1 more source

Evaluation of Flow Cytometry and Kleihauer Techniques for Quantification of Fetomaternal Hemorrhage: A Prospective Cohort Study in Southwestern Iran [PDF]

open access: yesHospital Practices and Research, 2018
Background: Quantification of fetal red blood cells (RBCs) in maternal blood is of great importance to calculate appropriate dose of post-deliver anti D immunoglobulin in a rhesus D (RhD)-negative woman.
Zeinab Keshavarz   +6 more
doaj   +1 more source

Predictive factors of response to splenectomy in children with immune thrombocytopenic purpura [PDF]

open access: yesAin-Shams Journal of Surgery, 2014
Background: Immune thrombocytopenic purpura (JTP) is an acquired disorder of unknown cause in which autoantibodies  are directed against antigens on the platelet membrane.
Hassan S. Badr, Tamer Fakhry
doaj   +1 more source

Avaliação da hemorragia feto-materna em puérperas com indicação para ministração de imunoglobulina anti-D Evaluation of fetomaternal hemorrhage in postpartum patients with indication for administration of anti-D immunoglobulin

open access: yesCadernos de Saúde Pública, 2005
Avaliamos a ocorrência da hemorragia feto-materna entre 343 puérperas que receberiam profilaxia da aloimunização Rh com emprego de imunoglobulina anti-D.
Eduardo Baiochi   +2 more
doaj   +1 more source

Severe Refractory Immune Thrombocytopenia Successfully Treated with High-Dose Pulse Cyclophosphamide and Eltrombopag

open access: yesCase Reports in Hematology, 2015
Severe refractory ITP is clinically challenging and a variety of single or combination chemotherapies have been tried with limited outcome. We report a case of ITP that was unresponsive to multiple agents including high-dose steroid, IVIG, Rho(D) immune ...
Faiz Anwer   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy